Immediate Management: Stop Breastfeeding and Assess Hydration
If an infant develops severe diarrhea while the mother is taking Invanz (ertapenem), immediately discontinue breastfeeding and assess the infant for dehydration, as ertapenem is excreted in breast milk and diarrhea is a known adverse effect of this medication. 1
Key Evidence from Drug Label
The FDA label for Invanz clearly documents that ertapenem is present in breast milk. In nursing mothers receiving 1g daily, breast milk concentrations ranged from less than 0.13 mcg/mL (lower limit of quantitation) to 0.38 mcg/mL 1. While these are relatively low concentrations, diarrhea is a well-documented adverse effect of ertapenem in both adults and children 1, 2.
Immediate Clinical Actions
1. Stop Breastfeeding Immediately
- Discontinue all breast milk exposure (direct nursing and expressed milk)
- This is the most critical intervention based on the temporal relationship between drug exposure and symptoms
2. Assess Dehydration Severity
Look for these specific signs in the infant:
- Mild-moderate dehydration: Decreased urine output, dry mucous membranes, decreased skin turgor, sunken fontanelle
- Severe dehydration: Altered mental status, poor perfusion, weak pulse, lethargy
3. Initiate Rehydration Based on Severity
For mild-moderate dehydration 3:
- Oral rehydration solution (ORS): 60-120 mL for each diarrheal stool (for infants <10 kg)
- Use low-osmolarity ORS products like Pedialyte
- Continue until clinical dehydration resolves
- Do NOT use apple juice, Gatorade, or soft drinks
For severe dehydration 3:
- Immediate intravenous isotonic crystalloid boluses (lactated Ringer's or normal saline)
- Administer up to 20 mL/kg until pulse, perfusion, and mental status normalize
- Once stabilized, transition to ORS for remaining deficit replacement
Expected Timeline for Resolution
Based on similar case reports with other medications excreted in breast milk 4, diarrhea should cease within 24-48 hours after stopping breastfeeding. If diarrhea persists beyond 48-72 hours after discontinuing breast milk exposure, investigate alternative causes including:
- Viral gastroenteritis
- Bacterial infection
- Other feeding-related issues
Important Caveats
Do not assume all infant diarrhea during maternal antibiotic use is drug-related. The differential diagnosis must include:
- Clostridioides difficile infection (though rare in exclusively breastfed infants)
- Viral gastroenteritis (more common)
- Bacterial pathogens
- Formula intolerance if supplementing
However, given the temporal relationship and known adverse effect profile of ertapenem 2, drug exposure via breast milk is the most likely culprit requiring immediate intervention.
Feeding After Resolution
Once diarrhea resolves (typically 24-48 hours after stopping breastfeeding):
- Switch to formula feeding for the duration of maternal ertapenem therapy
- Ertapenem becomes undetectable in breast milk by day 5 after discontinuation 1
- Mother can resume breastfeeding 5-7 days after completing her antibiotic course
Monitoring During Recovery
- Track number of wet diapers (should return to 6-8 per day)
- Monitor stool consistency and frequency
- Ensure adequate weight gain resumes
- Watch for electrolyte disturbances if dehydration was significant
The key principle here is that while most antibiotics are compatible with breastfeeding 5, when an infant develops severe adverse effects temporally related to maternal medication, immediate cessation of exposure takes priority over continuation of breastfeeding 6.